Drug delivery systems represent a range of technologies that enhance drug efficacy, reduce side effects, minimize dosage, improve patient compliance, and protect drugs from degradation in the body, thereby optimizing pharmacokinetics and bioavailability. They achieve this by controlling the rate, site, and duration of drug release within the body. These systems enable timed and targeted drug release, simplify dosing protocols, and hold particular significance for the treatment of chronic and complex diseases such as cancer and diabetes. With technological advancements, modern drug delivery systems not only deliver medications but also integrate diagnostic, therapeutic, and monitoring capabilities, offering new possibilities for personalized medicine and enhancing patients’ quality of life. Macrocyclic compounds play a pivotal role in drug delivery systems (
Fig. 3) [
5,
6]. They can enhance the water solubility and bioavailability of poorly soluble drugs through solubilization, achieve targeted drug delivery through molecular recognition techniques to minimize damage to normal tissues, and be designed to be sensitive to specific stimuli such as pH changes or light exposure, enabling controlled drug release in specific environments and reducing systemic toxicity. Additionally, macrocyclic compounds protect drug molecules from adverse environmental effects, ensuring their stability until they reach the site of action. Furthermore, they can serve as components of multifunctional nano-drug delivery systems, integrating diagnostic and therapeutic functions, demonstrating broad application potential within nanotechnology. Due to their unique functionalities compared to traditional drug delivery systems, the development of drug delivery systems based on macrocyclic host molecules is garnering increasing attention in recent years.